A passion play for plasma-rich platelet treatment

A health care worker who says being in business was never a goal has managed to build a 40-employee, niche industry leader. How has he sustained the success?


EmCyte founder, chairman and CEO Patrick Pennie turned experiments with platelet-rich plasma treatments into a global enterprise. Photo by JimJett.com
EmCyte founder, chairman and CEO Patrick Pennie turned experiments with platelet-rich plasma treatments into a global enterprise. Photo by JimJett.com
  • Health Care
  • Share

Patrick Pennie is profusely passionate about patient care and treatment outcome.

That’s how the former cardiac surgery perfusionist pioneered and proliferated platelet-rich plasma and progenitor stem cell biologics treatments for injuries and non-healing wounds. (A perfusionist operates a heart-lung machine.)

 

Continue reading your article
with a Business Observer subscription.
What's included:
  • ✓ Unlimited digital access to BusinessObserverFL.com
  • ✓ E-Newspaper app, digital replica of print edition
  • ✓ Mailed print newspaper every Friday (optional)
  • ✓ Newsletter of daily business news

Latest News

  • December 15, 2025
Lee Health CEO to step down

Sponsored Content